Printer Friendly

DAVID R. BETHUNE NAMED FOUNDING TRUSTEE OF NEWLY FORMED AMERICAN CANCER SOCIETY FOUNDATION

 DAVID R. BETHUNE NAMED FOUNDING TRUSTEE
 OF NEWLY FORMED AMERICAN CANCER SOCIETY FOUNDATION
 /ADVANCE/ WAYNE, N.J., Aug. 21 /PRNewswire/ -- David R. Bethune, president of Lederle Laboratories, has been named a founding Trustee of the American Cancer Society Foundation, the company announced today.
 "I'm honored with the privilege of serving as a Trustee of the American Cancer Society Foundation, and I'm looking forward to playing an active role with this new organization," said Bethune. "Lederle has for years worked with various medical societies and patient advocacy groups to support the overall fight against cancer, and now we at Lederle have another tremendous opportunity to become involved in future programs with this Foundation that will help patients and cancer researchers alike."
 Lederle Laboratories has long been a leader in the fight against cancer, and has the distinction of being the first pharmaceutical company to engage in a dedicated chemotherapy research and development program. As president of Lederle Laboratories, Bethune has provided leadership and vision for the company's efforts to reduce the morbidity and mortality of this devastating disease.
 Lederle Laboratories, a division of American Cyanamid Company (NYSE: ACY), is a research intensive organization that manufactures and markets worldwide a variety of pharmaceutical products, including ethical pharmaceuticals, vaccines, generics and vitamins/nutritionals.
 -0- 8/21/92
 /CONTACT: Craig R. Engesser of Lederle Laboratories, 201-831-3253/
 (ACY) CO: Lederle Laboratories; American Cancer Society Foundation ST: New Jersey IN: SU:


BN-BR -- AT011 -- 1738 08/20/92 13:08 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Aug 20, 1992
Words:244
Previous Article:F & C BANCSHARES TO REPURCHASE UP TO 5 PERCENT OF COMMON STOCK
Next Article:SYMIX SYSTEMS, INC. REPORTS RESULTS FOR FOURTH QUARTER AND FISCAL YEAR END
Topics:


Related Articles
IVAX Appoints David R. Bethune as President and COO
Northwest Biotherapeutics Issued U.S. Patent for Prostate Cancer Immunotherapy
Ralph Destino Elected Secretary of American Cancer Society Foundation.
[2] Ralph Destino Elected Secretary of American Cancer Society Foundation.
Retail CEO Irwin Belk Elected President of The American Cancer Society Foundation.
Gary M. Reedy elected to American Cancer Society Foundation Board of Trustees.
Pickett Appointed President of Schering-Plough Research Institute; Spicehandler Appointed Chairman of Schering-Plough Research Institute.
Main Treatment Options for Prostate Cancer Have Same Cure Rates.
Women Urged to Get Screened for Cervical Cancer During January, Cervical Cancer Screening Month; National Cervical Cancer Public Education Campaign...

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters